{
  "id": "42e407b3001e85bf",
  "title": "STAT+: Dispute between Corcept Therapeutics, FDA runs deep",
  "description": "A liver-safety risk puts the future of Corcept Therapeutics' experimental drug in doubt.",
  "content": "A liver-safety risk puts the future of Corcept Therapeutics' experimental drug in doubt.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/05/corcept-therapeutics-fda-relacorilant-cushings-disease/?utm_campaign=rss",
  "published_at": "2026-02-05T11:30:00+00:00",
  "fetched_at": "2026-02-06T00:27:14.258190+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Dispute between Corcept Therapeutics, FDA runs deep",
    "description": "A liver-safety risk puts the future of Corcept Therapeutics' experimental drug in doubt.",
    "url": "https://www.statnews.com/2026/02/05/corcept-therapeutics-fda-relacorilant-cushings-disease/?utm_campaign=rss",
    "published": "2026-02-05T11:30:00+00:00",
    "source": "STAT"
  }
}